Skip to main content
FDA approves DreaMed's diabetes-management software

Israeli firm DreaMed Diabetes' diabetes-management software Advisor Pro has been approved for marketing by the FDA. The software is designed to help health care providers manage type 1 diabetes patients who use continuous glucose monitoring and insulin pumps and provides insulin delivery recommendations.

Full Story: